Pathophysiology and Diagnostics of Immune Thrombocytopenia

被引:0
|
作者
Giagounidis, Aristoteles [1 ]
机构
[1] Marien Hosp, Klin Onkol Hamatol & Palliativmed, Rochusstr 2, D-40479 Dusseldorf, Germany
关键词
immune thrombocytopenia; pathophysiology; diagnostics; ANTIPLATELET AUTOANTIBODIES; PLATELET PRODUCTION; PURPURA; PLASMA; PATHOGENESIS; MICROBIOTA; KINETICS; RISK;
D O I
10.1055/a-2317-3073
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune thrombocytopenia (ITP) is due to autoantibodies against platelet surface antigens. ITP is considered as either primary, with no clear etiology, or as secondary ITP (drug-induced; underlying diseases). Autoantibodies lead both to loss of platelets in the spleen and/or liver but simultaneously reduce their production. Contrary to other disorders with thrombocytopenia, ITP has reduced levels of thrombopoetin. ITP remains a diagnosis of exclusion. A single defining laboratory test does not exist. Glycoprotein-specific antibodies can be detected in only about 50% of cases. Ruling out EDTA-induced pseudo thrombocytopenia is of particular relevance. Secondary causes of thrombocytopenia should be excluded through medical history (especially medication history), physical examination and possibly bone-marrow puncture.
引用
收藏
页码:832 / 838
页数:7
相关论文
共 50 条
  • [41] Efgartigimod alfa for the treatment of primary immune thrombocytopenia
    Broome, Catherine
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [42] Perinatal Outcome of Pregnancies Complicated by Immune Thrombocytopenia
    Jahromi, B. Namavar
    Shiravani, Z.
    Salarian, L.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2012, 14 (07) : 430 - 435
  • [43] Biomarkers for immune thrombocytopenia
    Lingjia Yu
    Chunmei Zhang
    Liping Zhang
    Yongyu Shi
    Xuebin Ji
    Biomarker Research, 3 (1)
  • [44] Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment
    Georgoudis, Panagiotis
    Sabatino, Francesco
    Szentmary, Nora
    Palioura, Sotiria
    Fodor, Eszter
    Hamada, Samer
    Scholl, Hendrik P. N.
    Gatzioufas, Zisis
    OPHTHALMOLOGY AND THERAPY, 2019, 8 (01) : 5 - 17
  • [45] Multicenter, prospective study to evaluate the efficacy of biweekly romiplostim administration in patients with immune thrombocytopenia
    Park, Silvia
    Yoon, Sung Soo
    Lee, Jung Hee
    Park, Joon Seong
    Jang, Jun Ho
    Lee, Jong Wook
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (01) : 44 - 52
  • [46] Immune thrombocytopenia: current diagnostics and therapy . The new 2023 expert report in brief
    Uzun, Guenalp
    Bakchoul, Tamam
    Lengerke, Claudia
    Moyses, Margarete
    INNERE MEDIZIN, 2024,
  • [47] T cell immune abnormalities in immune thrombocytopenia
    Xuebin Ji
    Liping Zhang
    Jun Peng
    Ming Hou
    Journal of Hematology & Oncology, 7
  • [48] T cell immune abnormalities in immune thrombocytopenia
    Ji, Xuebin
    Zhang, Liping
    Peng, Jun
    Hou, Ming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [49] Severe immune thrombocytopenia in two patients with systemic sclerosis
    Boleto, Goncalo
    Avouac, Jerome
    Godeau, Bertrand
    Allanore, Yannick
    JOINT BONE SPINE, 2023, 90 (04)
  • [50] Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom
    Bennett, Dimitri
    Hodgson, M. Elizabeth
    Shukla, Amit
    Logie, John W.
    ADVANCES IN THERAPY, 2011, 28 (12) : 1096 - 1104